Mörs Katharina, Kany Shinwan, Hörauf Jason-Alexander, Wagner Nils, Neunaber Claudia, Perl Mario, Marzi Ingo, Relja Borna
Borna Relja, Department of Trauma, Hand and Reconstructive Surgery, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt, Germany,
Croat Med J. 2018 Apr 30;59(2):46-55. doi: 10.3325/cmj.2018.59.46.
To evaluate protective immunosuppressive dose and time-dependent effects of ethanol in an in vitro model of acute inflammation in human Chang liver cells.
The study was performed in 2016 and 2017 in the research laboratory of the Department of Trauma, Hand and Reconstructive Surgery, the University Hospital of the Goethe-University Frankfurt. Chang liver cells were stimulated with either interleukin (IL)-1β or IL-6 and subsequently treated with low-dose ethanol (85 mmol/L) or high-dose ethanol (170 mmol/L) for one hour (acute exposure) or 72 hours (subacute exposure). IL-6 and IL-1β release were determined by enzyme-linked immunosorbent assay. Neutrophil adhesion to Chang liver monolayers, production of reactive oxygen species, and apoptosis or necrosis were analyzed.
Contrary to high-dose ethanol, acute low-dose ethanol exposure significantly reduced IL-1β-induced IL-6 and IL-6-induced IL-1β release (P<0.05). Subacute ethanol exposure did not change proinflammatory cytokine release. Acute low-dose ethanol exposure significantly decreased inflammation-induced formation of reactive oxygen species (P<0.05) and significantly improved cell survival (P<0.05). Neither acute nor subacute high-dose ethanol exposure significantly changed inflammation-induced changes in reactive oxygen species or survival. Acute and subacute ethanol exposure, independently of the dose, significantly decreased neutrophil adhesion to inflamed Chang liver cells (P<0.05).
Acute treatment of inflamed Chang liver cells with ethanol showed its immunosuppressive potential. However, the observed effects were limited to low-dose setting, indicating the relevance of ethanol dose in the modulation of inflammatory cell response.
在人张氏肝细胞急性炎症的体外模型中评估乙醇的保护性免疫抑制剂量和时间依赖性效应。
该研究于2016年和2017年在法兰克福歌德大学大学医院创伤、手部及重建外科的研究实验室进行。张氏肝细胞用白细胞介素(IL)-1β或IL-6刺激,随后用低剂量乙醇(85 mmol/L)或高剂量乙醇(170 mmol/L)处理1小时(急性暴露)或72小时(亚急性暴露)。通过酶联免疫吸附测定法测定IL-6和IL-1β的释放。分析中性粒细胞对张氏肝单层细胞的黏附、活性氧的产生以及细胞凋亡或坏死情况。
与高剂量乙醇相反,急性低剂量乙醇暴露显著降低了IL-1β诱导的IL-6释放以及IL-6诱导的IL-1β释放(P<0.05)。亚急性乙醇暴露未改变促炎细胞因子的释放。急性低剂量乙醇暴露显著降低了炎症诱导的活性氧形成(P<0.05),并显著改善了细胞存活(P<0.05)。急性和亚急性高剂量乙醇暴露均未显著改变炎症诱导的活性氧变化或细胞存活情况。急性和亚急性乙醇暴露,无论剂量如何,均显著降低了中性粒细胞对炎症张氏肝细胞的黏附(P<0.05)。
乙醇对炎症张氏肝细胞的急性处理显示出其免疫抑制潜力。然而,观察到的效应仅限于低剂量情况,表明乙醇剂量在调节炎症细胞反应中的相关性。